The weekly litigation news digest is live. Subscribe now

IP Verse

Pharmaceutical Product With Increased Stability Comprising Immunoglobulins - EP3226895

The patent EP3226895 was granted to CSL Behring on Jul 22, 2020. The application was originally filed on Dec 3, 2015 under application number EP15805446A. The patent is currently recorded with a legal status of "Granted And Under Opposition".

EP3226895

CSL BEHRING
Application Number
EP15805446A
Filing Date
Dec 3, 2015
Status
Granted And Under Opposition
Jun 19, 2020
Publication Date
Jul 22, 2020
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status

Get instant alerts for new oppositions and patent status changes

OCTAPHARMAApr 22, 2021ULLRICH & NAUMANN PARTG MBB -

Patent Citations (17) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication Number
EXAMINATIONEP2361636
EXAMINATIONEP3202389
INTERNATIONAL-SEARCH-REPORTEP2361636
INTERNATIONAL-SEARCH-REPORTFR2995213
INTERNATIONAL-SEARCH-REPORTGB2471726
INTERNATIONAL-SEARCH-REPORTWO03039632
INTERNATIONAL-SEARCH-REPORTWO2012151247
INTERNATIONAL-SEARCH-REPORTWO2014140095
INTERNATIONAL-SEARCH-REPORTWO2014140097
OPPOSITIONFR2995213
OPPOSITIONUS2005276823
OPPOSITIONUS2008072992
OPPOSITIONUS2015224264
OPPOSITIONWO03039632
OPPOSITIONWO2007100396
OPPOSITIONWO2011104315
OPPOSITIONWO2014140097

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents